26.87
price down icon0.11%   -0.03
after-market 시간 외 거래: 27.70 0.83 +3.09%
loading

Tourmaline Bio Inc 주식(TRML)의 최신 뉴스

pulisher
08:08 AM

AlphaCentric Advisors LLC Sells 69,500 Shares of Tourmaline Bio, Inc. (NASDAQ:TRML) - MarketBeat

08:08 AM
pulisher
01:25 AM

Tourmaline Bio shares get buy rating on IL-6 study optimism - Investing.com Canada

01:25 AM
pulisher
Nov 02, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DICE, Q - GuruFocus.com

Nov 02, 2024
pulisher
Oct 31, 2024

The Best Curling Irons, Based On Several Months Of Testing - Forbes

Oct 31, 2024
pulisher
Oct 31, 2024

Tourmaline Bio to Present at Upcoming Investor Conferences - The Manila Times

Oct 31, 2024
pulisher
Oct 27, 2024

Short Interest in Tourmaline Bio, Inc. (NASDAQ:TRML) Declines By 20.0% - MarketBeat

Oct 27, 2024
pulisher
Oct 18, 2024

Cantor Fitzgerald Predicts Tourmaline Bio FY2024 Earnings - Defense World

Oct 18, 2024
pulisher
Oct 17, 2024

Tourmaline Bio, Inc. to Post FY2024 Earnings of ($2.85) Per Share, Cantor Fitzgerald Forecasts (NASDAQ:TRML) - MarketBeat

Oct 17, 2024
pulisher
Oct 17, 2024

Cantor Fitzgerald Upgrades Tourmaline Bio (NASDAQ:TRML) to “Strong-Buy” - Defense World

Oct 17, 2024
pulisher
Oct 16, 2024

Tourmaline Bio (NASDAQ:TRML) Shares Up 6.3%Here's What Happened - MarketBeat

Oct 16, 2024
pulisher
Oct 16, 2024

Tourmaline Bio Insiders Placed Bullish Bets Worth US$643.3k - Simply Wall St

Oct 16, 2024
pulisher
Oct 16, 2024

Keros Therapeutics appoints new Chief Medical Officer - Investing.com

Oct 16, 2024
pulisher
Oct 16, 2024

Keros Therapeutics Appoints Yung H. Chyung, M.D., as Chief Medical Officer - GlobeNewswire

Oct 16, 2024
pulisher
Oct 16, 2024

Cantor Fitzgerald Upgrades Tourmaline Bio (NASDAQ:TRML) to Strong-Buy - MarketBeat

Oct 16, 2024
pulisher
Oct 16, 2024

Keros Therapeutics appoints new Chief Medical Officer By Investing.com - Investing.com Canada

Oct 16, 2024
pulisher
Oct 15, 2024

Tourmaline Bio (NASDAQ:TRML) Shares Gap UpStill a Buy? - MarketBeat

Oct 15, 2024
pulisher
Oct 15, 2024

Tourmaline Bio to Host Expert Webinar on Human Genetic Validation for IL-6 Inhibition in Cardiovascular Disease with Dr. Dipender Gill on Friday, November 1, 2024 - The Manila Times

Oct 15, 2024
pulisher
Oct 15, 2024

Palvella Therapeutics Announces Presentations at the 12th Pediatric Dermatology Research Alliance (PeDRA) Annual Conference - The Manila Times

Oct 15, 2024
pulisher
Oct 15, 2024

Tourmaline Bio to Host Expert Webinar on Human Genetic Validation for IL-6 Inhibition in ... - The Bakersfield Californian

Oct 15, 2024
pulisher
Oct 14, 2024

TRMLTourmaline Bio, Inc. Latest Stock News & Market Updates - StockTitan

Oct 14, 2024
pulisher
Oct 14, 2024

Investing in Tourmaline Bio Inc (TRML): What You Must Know - Knox Daily

Oct 14, 2024
pulisher
Oct 13, 2024

Tourmaline Bio: Looking To Go Beyond FcRn Inhibition With IL-6 Targeting (NASDAQ:TRML) - Seeking Alpha

Oct 13, 2024
pulisher
Oct 13, 2024

Cubist Systematic Strategies LLC Purchases Shares of 37,861 Tourmaline Bio, Inc. (NASDAQ:TRML) - MarketBeat

Oct 13, 2024
pulisher
Oct 13, 2024

Tourmaline Bio (NASDAQ:TRML) Shares Gap Down – Time to Sell? - Defense World

Oct 13, 2024
pulisher
Oct 11, 2024

Tourmaline Bio (NASDAQ:TRML) Shares Gap DownTime to Sell? - MarketBeat

Oct 11, 2024
pulisher
Oct 11, 2024

Guggenheim reiterates Buy on Tourmaline Bio shares, keeps price target By Investing.com - Investing.com UK

Oct 11, 2024
pulisher
Oct 11, 2024

Tourmaline Bio to present research at Cardiometabolic Congress By Investing.com - Investing.com South Africa

Oct 11, 2024
pulisher
Oct 11, 2024

Tourmaline Bio to present research at Cardiometabolic Congress - Investing.com

Oct 11, 2024
pulisher
Oct 11, 2024

Tourmaline Bio to Showcase Two Poster Presentations at the 2024 Cardiometabolic Health Congress - The Manila Times

Oct 11, 2024
pulisher
Oct 11, 2024

Tourmaline Bio announces CMO resignation By Investing.com - Investing.com South Africa

Oct 11, 2024
pulisher
Oct 10, 2024

Tourmaline Bio announces CMO resignation - Investing.com India

Oct 10, 2024
pulisher
Oct 10, 2024

Tourmaline Bio’s Chief Medical Officer Resigns Amicably - TipRanks

Oct 10, 2024
pulisher
Oct 10, 2024

Tourmaline Bio, Inc. Announces Resignation of Yung Chyung as Chief Medical Officer,Effective October 31, 2024 - Marketscreener.com

Oct 10, 2024
pulisher
Oct 10, 2024

Tourmaline Bio, Inc. (NASDAQ:TRML) Receives Consensus Rating of "Buy" from Analysts - MarketBeat

Oct 10, 2024
pulisher
Oct 09, 2024

Marquette Asset Management LLC Raises Stake in Vera Bradley, Inc. (NASDAQ:VRA) - Defense World

Oct 09, 2024
pulisher
Oct 09, 2024

Tourmaline Bio (NASDAQ:TRML) Stock Price Down 4.3%Should You Sell? - MarketBeat

Oct 09, 2024
pulisher
Oct 08, 2024

Tourmaline Bio (NASDAQ:TRML) Trading 6.4% HigherStill a Buy? - MarketBeat

Oct 08, 2024
pulisher
Oct 08, 2024

Tourmaline Bio (NASDAQ:TRML) Trading 6.4% Higher – What’s Next? - Defense World

Oct 08, 2024
pulisher
Oct 08, 2024

Tourmaline Bio forms advisory board for heart drug By Investing.com - Investing.com South Africa

Oct 08, 2024
pulisher
Oct 08, 2024

Tourmaline Bio forms Cardiovascular Scientific Advisory Board - TipRanks

Oct 08, 2024
pulisher
Oct 08, 2024

Tourmaline Bio Announces Formation of Cardiovascular Scientific Advisory Board - The Manila Times

Oct 08, 2024
pulisher
Oct 07, 2024

Algert Global LLC Has $513,000 Position in Tourmaline Bio, Inc. (NASDAQ:TRML) - MarketBeat

Oct 07, 2024
pulisher
Oct 03, 2024

There is no way Tourmaline Bio Inc (TRML) can keep these numbers up - SETE News

Oct 03, 2024
pulisher
Oct 02, 2024

Keeping an Eye on Tourmaline Bio Inc (TRML) After Insider Trading Activity - Knox Daily

Oct 02, 2024
pulisher
Oct 02, 2024

Did Tourmaline Bio Inc (TRML) perform well in the last session? - US Post News

Oct 02, 2024
pulisher
Oct 02, 2024

Keeping an Eye on PubMatic Inc (PUBM) After Insider Trading Activity - Knox Daily

Oct 02, 2024
pulisher
Oct 02, 2024

Recent Insider Activity Suggests Potential Gains for Neogenomics Inc. (NEO) - Knox Daily

Oct 02, 2024
pulisher
Oct 01, 2024

Crew Energy Inc. Announces Completion of Acquisition By Tourmaline Oil Corp. - Yahoo Finance

Oct 01, 2024
pulisher
Sep 30, 2024

Graves’ Disease Treatment Market Size in the 7MM is expected to grow by 2034, estimates DelveInsight - The Globe and Mail

Sep 30, 2024
pulisher
Sep 28, 2024

Tourmaline Bio, Inc. (NASDAQ:TRML) Stock Position Boosted by Blue Owl Capital Holdings LP - MarketBeat

Sep 28, 2024
pulisher
Sep 27, 2024

Tourmaline Bio, Inc. (NASDAQ:TRML) Shares Purchased by Rhumbline Advisers - MarketBeat

Sep 27, 2024
pulisher
Sep 25, 2024

Tourmaline Bio (NASDAQ:TRML) Trading Up 2.5% - MarketBeat

Sep 25, 2024
pulisher
Sep 25, 2024

Tourmaline Bio (NASDAQ:TRML) Trading 2.5% Higher - Defense World

Sep 25, 2024
pulisher
Sep 25, 2024

S&P 500 Index (INX) QuotePress Release - The Globe and Mail

Sep 25, 2024
pulisher
Sep 24, 2024

HighVista Strategies LLC Purchases 30,345 Shares of Tourmaline Bio, Inc. (NASDAQ:TRML) - MarketBeat

Sep 24, 2024
pulisher
Sep 23, 2024

Tourmaline Bio (NASDAQ:TRML) Shares Down 5% - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

BridgeBio Pharma, Inc. (NASDAQ:BBIO) Shares Sold by HighVista Strategies LLC - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Was anything positive for Tourmaline Bio Inc (TRML) stock last session? - US Post News

Sep 23, 2024
pulisher
Sep 23, 2024

Monitoring Red Robin Gourmet Burgers Inc (RRGB) after recent insider movements - Knox Daily

Sep 23, 2024
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
자본화:     |  볼륨(24시간):